Sort
64,565 grants matching “drug discovery”
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning
$505,514Steven E Patterson · University Of Minnesota · U01 · FY2020 · NS
Microtubule Dynamics and Mitotic Mechanism
$505,486Timothy J Mitchison · Harvard Medical School · R01 · FY2009 · GM
Identification of Old-Age-Associated Alzheimer's Disease Drug Targets
$505,457David R Schubert · Salk Institute For Biological Studies · R01 · FY2018 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases
$505,452Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG
ANTI-ORTHOPOXVIRUS DRUG DISCOVERY AND DEVELOPMENT
$505,447Auburn University At Auburn · U01 · FY2003 · AI
The Center for Therapeutic Targeting of EWS-oncoproteins
$505,427Kimberly Stegmaier · Dana-Farber Cancer Inst · U54 · FY2022 · CA
Reposition and Optimization of Deferiprone for Breast Cancer Therapy
$505,386Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2021 · CA
ITM 2.0: Advancing Translational Science in Metropolitan Chicago
$505,343Julian Solway · University Of Chicago · UL1 · FY2018 · TR
Chemoproteomic methods for serine hydrolase inhibitor development
$505,322Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2015 · DA
PHYSIOLOGY AND GENETICS OF GDNF FAMILY OF LIGANDS
$505,321Jeffrey D Milbrandt · Washington University · R01 · FY2015 · AG
Gonococci: Genetics of Resistance to PMN Proteins
$505,297William Maurice Shafer · Emory University · R01 · FY2021 · AI
Drug Discovery for Fatty Acid Synthase in Oncology
$505,254Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
$505,241Thomas A Kensler · Johns Hopkins University · P01 · FY2009 · ES
Long-lived mice and species as test beds for drug and pathway discovery
$505,220Richard A. Miller · California Pacific Med Ctr Res Institute · U19 · FY2020 · AG
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$505,143Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2020 · AI
Product Development Core
$505,023Julian P Whitelegge · University Of California Los Angeles · U19 · FY2015 · AI
Core F: Biomarker
$505,011Celeste Marie Karch · Washington University · P30 · FY2023 · AG
Chemoproteomic methods for serine hydrolase inhibitor development
$504,995Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2012 · DA
DISCOVERY OF IN VIVO CHEMICAL PROBES FOR POLYCOMB CBX DOMAINS
$504,942Stephen Vernon Frye · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Otitis Media-associated pneumococcal genes
$504,887Dennis W. Metzger · Albany Medical College · R01 · FY2010 · DC
Training program in cancer pharmacology
$504,858Ian Alexander Blair · University Of Pennsylvania · R25 · FY2013 · CA
Estrogen receptor mediated reprogramming of prostate in BPH
$504,821Paul S Cooke · University Of Florida · R01 · FY2021 · DK
USP7 inhibitors for the treatment of multiple myeloma
$504,721Sara J Buhrlage · Dana-Farber Cancer Inst · R01 · FY2017 · CA
USP7 inhibitors for the treatment of multiple myeloma
$504,721Sara J Buhrlage · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development
$504,685Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2020 · AI